The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Evan Konwiser See remarks | DDisposition to issuer Class A Common Stock | -177,377 | - | - | 0 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Andrew George Crawley President | DDisposition to issuer Class A Common Stock | -141 | - | - | 699,176 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Andrew George Crawley President | DDisposition to issuer Class A Common Stock | -699,176 | - | - | 0 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Andrew George Crawley President | DDisposition to issuer Class A Common Stock | -354,760 | - | - | 0 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Paul G Abbott Chief Executive Officer | DDisposition to issuer Class A Common Stock | -930,326 | - | - | 1,652,585 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Paul G Abbott Chief Executive Officer | DDisposition to issuer Class A Common Stock | -1,652,585 | - | - | 0 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Paul G Abbott Chief Executive Officer | DDisposition to issuer Class A Common Stock | -827,779 | - | - | 0 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Patricia Anne Huska Chief People Officer | DDisposition to issuer Class A Common Stock | -856,752 | - | - | 413,146 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Patricia Anne Huska Chief People Officer | DDisposition to issuer Class A Common Stock | -413,146 | - | - | 0 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Patricia Anne Huska Chief People Officer | DDisposition to issuer Class A Common Stock | -206,941 | - | - | 0 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Raymond Joabar director | DDisposition to issuer Class A Common Stock | -97,097 | - | - | 23,429 | 14 d ago |
| Sep 29, 2026 | GBTG Global Business Travel Group, Inc. | Raymond Joabar director | DDisposition to issuer Class A Common Stock | -23,429 | - | - | 0 | 14 d ago |
| Sep 25, 2026 | PONY Pony AI Inc. | Tiancheng Lou Chief Technology Officer | DDisposition to issuer Class A Ordinary Shares | -25,729 | $6.89 | $177k | 85,718 | 14 d ago |
| Apr 14, 2026 | ASND Ascendis Pharma A/S | Jean Jacques Bienaime director | DDisposition to issuer Warrantsderivative | -9,160 | - | - | 0 | 15 d ago |
| Sep 25, 2026 | LAD LITHIA MOTORS INC | Heidi O'Neill director | DDisposition to issuer Lithia Motors Inc Common Stock | -540 | $0.00 | $0 | 884 | 15 d ago |
| Sep 11, 2026 | SLG SL GREEN REALTY CORP | Marc Holliday Chief Executive Officer | DDisposition to issuer LTIP Unitsderivative | -92,025 | $54.85 | $5.0M | 1,432,523 | 15 d ago |
| Sep 25, 2026 | CNK Cinemark Holdings, Inc. | Valmir Fernandes Pr - Cinemark International | DDisposition to issuer Common Stockindirect: VF Trust10b5-1 | -38,000 | $38.00 | $1.4M | 68,386 | 15 d ago |
| Sep 24, 2026 | ACIW ACI WORLDWIDE, INC. | Robert William Leibrock Chief Financial Officer | DDisposition to issuer Common Stock | -3,176 | $49.62 | $158k | 200,725 | 18 d ago |
| Sep 24, 2026 | SPAI Safe Pro Group Inc. | Christopher Michael Todd President Airborne Response Co | DDisposition to issuer Common Stockindirect: By Christopher Todd Inc. | -25,000 | $4.00 | $100k | 695,000 | 18 d ago |
| Sep 23, 2026 | WHLR Wheeler Real Estate Investment Trust, Inc. | Joseph Stilwell director, owner | DDisposition to issuer Series D Cumulative Convertible Preferred Stockderivativeindirect: See footnote | -3,287 | - | - | 134,678 | 18 d ago |
| Sep 23, 2026 | WHLR Wheeler Real Estate Investment Trust, Inc. | Joseph Stilwell director, owner | DDisposition to issuer Series D Cumulative Convertible Preferred Stockderivativeindirect: See footnote | -6,575 | - | - | 128,103 | 18 d ago |
| Sep 23, 2026 | WHLR Wheeler Real Estate Investment Trust, Inc. | Joseph Stilwell director, owner | DDisposition to issuer Series D Cumulative Convertible Preferred Stockderivativeindirect: See footnote | -491 | - | - | 19,542 | 18 d ago |
| Sep 23, 2026 | WHLR Wheeler Real Estate Investment Trust, Inc. | Joseph Stilwell director, owner | DDisposition to issuer Series D Cumulative Convertible Preferred Stockderivativeindirect: See footnote | -955 | - | - | 18,587 | 18 d ago |
| Sep 23, 2026 | WHLR Wheeler Real Estate Investment Trust, Inc. | Joseph Stilwell director, owner | DDisposition to issuer Series D Cumulative Convertible Preferred Stockderivativeindirect: See footnote | -3,222 | - | - | 0 | 18 d ago |
| Sep 23, 2026 | WHLR Wheeler Real Estate Investment Trust, Inc. | Joseph Stilwell director, owner | DDisposition to issuer Series B Convertible Preferred Stockderivativeindirect: See footnote | -24,730 | - | - | 522,788 | 18 d ago |
| Sep 23, 2026 | WHLR Wheeler Real Estate Investment Trust, Inc. | Joseph Stilwell director, owner | DDisposition to issuer Series B Convertible Preferred Stockderivativeindirect: See footnote | -26,603 | - | - | 496,185 | 18 d ago |
| Sep 23, 2026 | WHLR Wheeler Real Estate Investment Trust, Inc. | Joseph Stilwell director, owner | DDisposition to issuer Series B Convertible Preferred Stockderivativeindirect: See footnote | -3,270 | - | - | 69,113 | 18 d ago |
| Sep 23, 2026 | WHLR Wheeler Real Estate Investment Trust, Inc. | Joseph Stilwell director, owner | DDisposition to issuer Series B Convertible Preferred Stockderivativeindirect: See footnote | -3,517 | - | - | 65,596 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Nadav Kidron President and CEO | DDisposition to issuer Stock option (right to buy)derivative | -196,500 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Nadav Kidron President and CEO | DDisposition to issuer Stock option (right to buy)derivative | -190,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Nadav Kidron President and CEO | DDisposition to issuer Stock option (right to buy)derivative | -49,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Nadav Kidron President and CEO | DDisposition to issuer Stock option (right to buy)derivative | -97,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Nadav Kidron President and CEO | DDisposition to issuer Stock option (right to buy)derivative | -150,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Nadav Kidron President and CEO | DDisposition to issuer Stock option (right to buy)derivative | -107,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Joshua Hexter COO & CBO | DDisposition to issuer Stock option (right to buy)derivative | -50,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Joshua Hexter COO & CBO | DDisposition to issuer Stock option (right to buy)derivative | -50,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Joshua Hexter COO & CBO | DDisposition to issuer Stock option (right to buy)derivative | -36,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Miriam Kidron Chief Scientific Officer | DDisposition to issuer Stock option (right to buy)derivative | -104,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Miriam Kidron Chief Scientific Officer | DDisposition to issuer Stock option (right to buy)derivative | -100,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Miriam Kidron Chief Scientific Officer | DDisposition to issuer Stock option (right to buy)derivative | -69,999 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Miriam Kidron Chief Scientific Officer | DDisposition to issuer Stock option (right to buy)derivative | -47,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Miriam Kidron Chief Scientific Officer | DDisposition to issuer Stock option (right to buy)derivative | -100,000 | - | - | 0 | 18 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Miriam Kidron Chief Scientific Officer | DDisposition to issuer Stock option (right to buy)derivative | -72,000 | - | - | 0 | 18 d ago |
| Sep 21, 2026 | CIB Grupo Cibest S.A. | Silvina Vatnick director | DDisposition to issuer Units in Grupo Cibest Equity Securities Fundderivativeindirect: Director Voluntary Pension Fund Units | -1,123 | $9.64 | $11k | 19,402 | 19 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Aine Miller SVP, DEV & HEAD OF IRE OFFICE | DDisposition to issuer Ordinary Shares | -93,108 | - | - | 96,718 | 19 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Aine Miller SVP, DEV & HEAD OF IRE OFFICE | DDisposition to issuer Ordinary Shares | -96,718 | - | - | 0 | 19 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Aine Miller SVP, DEV & HEAD OF IRE OFFICE | DDisposition to issuer Share Option (Right to Buy)derivative | -37,500 | - | - | 0 | 19 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY | DDisposition to issuer Ordinary Shares | -223,917 | - | - | 131,251 | 19 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY | DDisposition to issuer Ordinary Shares | -107,812 | - | - | 23,439 | 19 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY | DDisposition to issuer Ordinary Shares | -23,439 | - | - | 0 | 19 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.